LivaNova (LIVN) Current Deferred Tax Assets (2015)

LivaNova (LIVN) reported Current Deferred Tax Assets of $4.4 million for Q4 2015, down 39.14% sequentially from $7.2 million in Q2 2015.

LivaNova (LIVN) Current Deferred Tax Assets (2015) Analysis & Trends

LivaNova (LIVN) has 1 years of Current Deferred Tax Assets data on file, last reported at $4.4 million in Q4 2015.

For the quarter ending Q4 2015, Current Deferred Tax Assets changed N/A year-over-year to $4.4 million; the trailing twelve-month figure through Oct 2015 stood at $4.4 million (changed N/A YoY), and the FY2015 full-year result was $7.2 million, changed N/A from the prior year.
Current Deferred Tax Assets retreated to $4.4 million in Q4 2015, from $7.2 million in the prior quarter.
In the past five years, Current Deferred Tax Assets ranged from a high of $7.2 million in Q2 2015 to a low of $4.4 million in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	LivaNova	4.30 Bn	3.76 Bn	243.75 Mn

Download Data